Breaking News

SyVento Biotech Opens New mRNA Manufacturing Facility in Poland

a FlexFactory delivered by Cytiva, spans over 7,000 m2, including lab and production areas, offices, and shared spaces.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

SyVento Biotech has opened its new mRNA manufacturing facility, a FlexFactory delivered by Cytiva, spanning over 7,000 m2, including lab and production areas, offices, and shared spaces. This development represents a milestone for SyVento Biotech, enabling the CDMO to accelerate and enhance its service offerings.    It also establishes SyVento Biotech as a pioneer in the Polish market as it is the first mRNA FlexFactory in the country and the first in Europe equipped with the Historian automat...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters